<SEC-DOCUMENT>0001699031-25-000162.txt : 20250812
<SEC-HEADER>0001699031-25-000162.hdr.sgml : 20250812
<ACCEPTANCE-DATETIME>20250812160137
ACCESSION NUMBER:		0001699031-25-000162
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20250812
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250812
DATE AS OF CHANGE:		20250812

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			GRAIL, Inc.
		CENTRAL INDEX KEY:			0001699031
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MEDICAL LABORATORIES [8071]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				863673636
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-42045
		FILM NUMBER:		251206493

	BUSINESS ADDRESS:	
		STREET 1:		1525 O'BRIEN DRIVE
		CITY:			MENLO PARK
		STATE:			CA
		ZIP:			94025
		BUSINESS PHONE:		(833) 694-2553

	MAIL ADDRESS:	
		STREET 1:		1525 O'BRIEN DRIVE
		CITY:			MENLO PARK
		STATE:			CA
		ZIP:			94025

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	GRAIL, LLC
		DATE OF NAME CHANGE:	20231113

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Grail, Inc.
		DATE OF NAME CHANGE:	20170227
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>gral-20250812.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:57da9d89-77bb-4c54-806c-dfb4b2da70cb,g:3977d86e-9362-479c-ad17-043a818fc942,d:c643577dc69341698d771d4241b244af-->
<html xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns="http://www.w3.org/1999/xhtml" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>gral-20250812</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-24">0001699031</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" format="ixt:fixed-false" id="f-25">FALSE</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="gral-20250812.xsd"/></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001699031</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-08-12</xbrli:startDate><xbrli:endDate>2025-08-12</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="ic643577dc69341698d771d4241b244af_4"></div><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6pt;font-weight:700;line-height:120%">_____________________________________________</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">8-K</ix:nonNumeric></span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6pt;font-weight:700;line-height:120%">_____________________________________________</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">Pursuant to Section 13 or 15(d)</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">of the Securities Exchange Act of 1934</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">Date of Report (Date of earliest event reported): <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-2">August&#160;12, 2025</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6pt;font-weight:700;line-height:120%">_____________________________________________</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:24pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-3">GRAIL, Inc.</ix:nonNumeric></span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(Exact Name of Registrant as Specified in Charter)</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6pt;font-weight:700;line-height:120%">___________________________________________</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.234%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-4">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">001-42045</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#231f20;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-6"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-7">86-3673636</ix:nonNumeric></ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:120%">(State or Other Jurisdiction</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:120%">of Incorporation)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:120%">(Commission</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:120%">File Number)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:120%">(IRS Employer</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:120%">Identification No.)</span></div></td></tr></table><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-8">1525 O&#8217;Brien Drive</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-9">Menlo Park</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="f-10">California</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-11"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-12">94025</ix:nonNumeric></ix:nonNumeric></span></div><div style="padding-left:18pt;padding-right:18pt;text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:120%">(Address of Principal Executive Offices)            (Zip Code)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Registrant&#8217;s telephone number, including area code: (<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-13">833</ix:nonNumeric>) <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-14">694-2553</ix:nonNumeric></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Not Applicable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:120%">(Former Name or Former Address, if Changed Since Last Report)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6pt;font-weight:700;line-height:120%">___________________________________________</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.696%"><tr><td style="width:0.1%"/><td style="width:2.687%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:96.013%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:WrittenCommunications" format="ixt:fixed-false" id="f-15">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:SolicitingMaterial" format="ixt:fixed-false" id="f-16">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementTenderOffer" format="ixt:fixed-false" id="f-17">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementIssuerTenderOffer" format="ixt:fixed-false" id="f-18">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"/><td style="width:39.264%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.957%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:39.267%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:120%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:120%">Trading</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:120%">Symbol(s)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:120%">Name of each exchange</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:700;line-height:120%">on which registered</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-19">Common Stock, par value $0.001 per share</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-20">GRAL</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-21">The Nasdaq Global Select Market</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167; 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167; 240.12b-2 of this chapter). </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company  <ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-true" id="f-22">&#9746;</ix:nonNumeric></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. <ix:nonNumeric contextRef="c-1" name="dei:EntityExTransitionPeriod" format="ixt:fixed-true" id="f-23">&#9746;</ix:nonNumeric></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"/></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="ic643577dc69341698d771d4241b244af_7"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:11.778%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:86.022%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.02</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Results of operations and financial condition.</span></div></td></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On August&#160;12, 2025, GRAIL, Inc. (the &#8220;Company&#8221; or  &#8220;GRAIL&#8221;) issued a press release announcing its financial results for the second quarter ended June&#160;30, 2025. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The information in Item 2.02 of this Current Report on Form 8-K and the exhibits attached hereto are intended to be &#8220;furnished&#8221; and shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended. Except as shall be expressly set forth by specific reference in such filing, the information contained herein and in the accompanying exhibits shall not be incorporated by reference into any filing with the Securities and Exchange Commission made by the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.</span></div><div><span><br/></span></div><div id="ic643577dc69341698d771d4241b244af_10"></div><div style="-sec-extract:summary"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:11.778%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:86.022%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item 9.01</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Exhibits.</span></div></td></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(d) Exhibits</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:9.657%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:87.537%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Exhibit No.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Description</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="ex9912025q2earningspressre.htm">99.1</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="ex9912025q2earningspressre.htm">Press Release of GRAIL, Inc. dated </a><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="ex9912025q2earningspressre.htm">August</a><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="ex9912025q2earningspressre.htm"> 1</a><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="ex9912025q2earningspressre.htm">2</a><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="ex9912025q2earningspressre.htm">, 2025  (GRAIL Reports </a><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="ex9912025q2earningspressre.htm">Second</a><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="ex9912025q2earningspressre.htm"> Quarter 2025 Financial Results)</a></span></div></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="ic643577dc69341698d771d4241b244af_13"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="margin-top:30pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:4.217%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.589%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.341%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.341%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:37.012%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">GRAIL, INC.</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">August 12, 2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">/s/ Aaron Freidin</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Name:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Aaron Freidin</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Title: </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Chief Financial Officer</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex9912025q2earningspressre.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i31f92041a1ef47c1a35aab23b6b6fb59_1"></div><div style="min-height:108pt;width:100%"><div><img alt="grail_logoxvelvet.jpg" src="grail_logoxvelvet.jpg" style="height:39px;margin-bottom:5pt;vertical-align:text-bottom;width:211px"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div><font style="color:#330e74;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">NEWS RELEASE</font><font style="color:#4c16ae;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 99.1</font></div><div><font><br></font></div></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:16pt;font-weight:700;line-height:120%">GRAIL Reports Second Quarter 2025 Financial Results</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Q2 U.S. Galleri Revenue Grew 21% Year-Over-Year to $34.2 Million</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Q2 Galleri Tests Sold Grew 29% Year-Over-Year to More Than 45,000</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Detailed Results From First 25,000 Enrolled in PATHFINDER 2 to be Submitted for Presentation at ESMO 2025 in October</font></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">MENLO PARK, Calif. &#8212;  August&#160;12, 2025 &#8212; GRAIL, Inc. (Nasdaq&#58; GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today reported business and financial results for the second quarter 2025. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total revenue in the second quarter grew 11% year-over-year to $35.5 million, and Galleri revenue grew 22% year-over-year to $34.4 million. U.S. Galleri revenue was $34.2 million, representing 21% growth year-over-year. Net loss for the quarter was $114.0 million, which includes impairment of Illumina acquisition-related intangible assets of $28.0 million. Gross loss was $17.8 million. Non-GAAP adjusted gross profit was $16.1 million and non-GAAP adjusted EBITDA was $(78.3) million.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;We are pleased with Galleri&#8217;s growing uptake in the U.S., with more than 45,000 Galleri tests sold in the second quarter, as we continue to drive provider and patient awareness of the MCED opportunity and Galleri&#8217;s ability to detect cancer earlier, when it is more amenable to treatment,&#8221; said Bob Ragusa, Chief Executive Officer at GRAIL. &#8220;Our registrational trials in large, intended use populations in the U.S. and U.K. are beginning to read out, and following very promising top-line performance and safety results from the PATHFINDER 2 study in the U.S., we plan to submit detailed results for presentation at the European Society for Medical Oncology Congress 2025 in October.&#8221;</font></div><div><font><br></font></div><div style="margin-bottom:3pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended June&#160;30, 2025, as compared to the three months ended June&#160;30, 2024, GRAIL reported&#58;</font></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Revenue&#58;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Total revenue, comprised of screening and development services revenue, was $35.5 million, an increase of $3.6 million or 11%.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Net loss&#58;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Net loss was $114.0 million, an improvement of $1.5 billion or 93%. Net loss in the second quarter includes impairment of Illumina acquisition-related intangible assets of $28.0 million. In the second quarter of 2024, net loss included Illumina acquisition-related goodwill and intangible impairments of $1.42 billion.</font></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Gross loss&#58;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Gross loss was $17.8 million, an improvement of $0.1 million or 1%.</font></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Adjusted gross profit</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#58;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Adjusted gross profit was $16.1 million, an increase of $0.1 million or 1%.</font></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Adjusted EBITDA</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#58;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Adjusted EBITDA was $(78.3) million, an improvement of $61.1 million or 44%.</font></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Cash position&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash, cash equivalents, restricted cash and short-term marketable securities totaled $606.1 million as of June&#160;30, 2025.</font></div><div style="border-bottom:1pt solid #000000;margin-bottom:5pt;margin-top:10pt;opacity:1;width:150pt"></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> See &#8220;Non-GAAP Disclosure&#8221; and the associated reconciliations for important information about our use of non-GAAP measures.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><div id="i31f92041a1ef47c1a35aab23b6b6fb59_126"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:3pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Recent business highlights include&#58;</font></div><div style="margin-bottom:3pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Positive top-line performance and safety results from the pre-specified analysis of the first 25,578 participants in the registrational PATHFINDER 2 study were announced in June&#58;  </font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Adding Galleri to standard of care screening demonstrated substantially greater additional cancer detection than that observed in the first PATHFINDER study. The first PATHFINDER study showed a more than doubling of the overall number of cancers detected when added to standard of care.</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Positive predictive value (PPV) was substantially higher than the 43% PPV observed in the first PATHFINDER study.</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Specificity and cancer signal origin (CSO) accuracy were consistent with the 99.5% and 88%, respectively, observed in the first PATHFINDER study. There were no serious safety concerns reported in PATHFINDER 2.</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">These data follow positive top-line results from the prevalent screening round of the registrational NHS-Galleri trial, which showed a substantially higher PPV than that observed in the PATHFINDER study. CSO accuracy and specificity were consistent with those observed in the PATHFINDER study.  </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Entered a new collaboration with Everlywell, a digital health company pioneering the next generation of biomarker intelligence, to expand access to the Galleri test. Galleri is now available for request directly on everlywell.com via prescription. </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In July, Rush University System for Health, one of the largest health systems in the U.S., announced it is the first health system in the Chicago-area market to offer the Galleri test. </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Data presented at the American Society of Clinical Oncology (ASCO) Annual Meeting in May included a 5-year follow up analysis of the Circulating Cell-free Genome Atlas (CCGA) study, which demonstrated Galleri's preferential detection of aggressive, clinically meaningful cancers. (https&#58;&#47;&#47;assets.grail.com&#47;wp-content&#47;uploads&#47;2025&#47;05&#47;Swanton.ASCO-2025.CCGA-5-Year-Outcomes.Oral-Presentation_FINAL-1.pdf.) Findings are consistent with earlier analyses assessing the prognostic significance of Galleri&#8217;s cfDNA-based methylation approach. </font></div><div style="margin-bottom:3pt"><font><br></font></div><div id="i31f92041a1ef47c1a35aab23b6b6fb59_7"></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Conference Call and Webcast</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A webcast and conference call will be held today,</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">August&#160;12, 2025, at 1&#58;30 p.m. PT &#47; 4&#58;30 p.m. ET. Individuals interested in listening to the conference call may access it on the investor relations section of GRAIL&#8217;s website at investors.grail.com.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A replay of the webcast will be available on GRAIL&#8217;s website for 30 days.</font></div><div><font><br></font></div><div id="i31f92041a1ef47c1a35aab23b6b6fb59_10"></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">About GRAIL</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GRAIL, Inc. is a healthcare company whose mission is to detect cancer early, when it can be cured. GRAIL is focused on alleviating the global burden of cancer by using the power of next-generation sequencing, population-scale clinical studies, and state-of-the-art machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. GRAIL&#8217;s targeted methylation-based platform can support the continuum of care for screening and precision oncology, including multi-cancer early detection in symptomatic patients, risk stratification, minimal residual disease detection, biomarker subtyping, treatment and recurrence monitoring. GRAIL is headquartered in Menlo Park, CA with locations in Washington, D.C., North Carolina, and the United Kingdom. GRAIL&#8217;s common stock is listed under the ticker symbol &#8220;GRAL&#8221; on the NASDAQ Stock Exchange. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For more information, visit </font><font style="color:#3051f2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">grail.com</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">About Galleri&#174; </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Galleri multi-cancer early detection test is a proactive tool to screen for cancer. With a simple blood draw, the Galleri test can identify DNA shed by cancer cells, which can act as a unique &#34;fingerprint&#34; of cancer, to help screen for some of the deadliest cancers that don&#8217;t have recommended screening today, such as pancreatic, esophageal, ovarian, liver, and others. The Galleri test can be used to screen for cancer before a person becomes symptomatic, when cancer may be more easily treated and potentially curable. The Galleri test can indicate the origin of the cancer, giving healthcare providers a roadmap of where to explore further. The Galleri test requires a prescription from a licensed healthcare provider and should be used in addition to recommended cancer screenings such as mammography, colonoscopy, prostate-specific antigen (PSA) test, or cervical cancer screening. The Galleri test is recommended for adults with an elevated risk for cancer, such as those aged 50 or older.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For more information, visit </font><font style="color:#3051f2;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">galleri.com</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Laboratory&#47;Test Information</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GRAIL&#8217;s clinical laboratory is certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) and accredited by the College of American Pathologists. The Galleri test was developed, and its performance characteristics were determined by GRAIL. The Galleri test has not been cleared or approved by the U.S. Food and Drug Administration. GRAIL&#8217;s clinical laboratory is regulated under CLIA to perform high-complexity testing. The Galleri test is intended for clinical purposes.</font></div><div id="i31f92041a1ef47c1a35aab23b6b6fb59_13"></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-GAAP Disclosure</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to our financial results provided throughout this press release that are determined in accordance with U.S. generally accepted accounting principles (&#8220;GAAP&#8221;), this press release also includes financial measures that are not calculated in accordance with GAAP. Our non-GAAP financial disclosure includes Adjusted Gross Profit (Loss) and Adjusted EBITDA. We encourage investors to carefully consider our results under GAAP in conjunction with our supplemental non-GAAP information and the reconciliation between these presentations. </font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Adjusted Gross Profit (Loss) is a key performance measure that our management uses to assess our operational performance, as it represents the results of revenues and direct costs, which are key components of our operations. We believe that this non-GAAP financial measure is useful to investors and other interested parties in analyzing our financial performance because it reflects the gross profitability of our operations, and excludes the costs associated with our sales and marketing, product development, general and administrative activities, and depreciation and amortization, and the impact of our financing methods and income taxes.<br><br>We calculate Adjusted Gross Profit (Loss) as gross profit (loss) (as defined below) adjusted to exclude amortization of intangible assets and stock-based compensation allocated to cost of revenue. Adjusted Gross Profit (Loss) should be viewed as a measure of operating performance that is a supplement to, and not a substitute for, operating income or loss from operations, net earnings or loss and other GAAP measures of income (loss) or profitability. The following table presents a reconciliation of gross loss, the most directly comparable financial measure calculated in accordance with GAAP, to Adjusted Gross Profit.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Adjusted EBITDA is a key performance measure that our management uses to assess our financial performance and is also used for internal planning and forecasting purposes. We believe that this non-GAAP financial measure is useful to investors and other interested parties in analyzing our financial performance because it provides a comparable overview of our operations across historical periods. In addition, we believe that providing Adjusted EBITDA, together with a reconciliation of net income (loss) to Adjusted EBITDA, helps investors make comparisons between our company and other companies that may have different capital structures, different tax rates, different operational and ownership histories, and&#47;or different forms of employee compensation.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><br><br>Adjusted EBITDA is used by our management team as an additional measure of our performance for purposes of business decision-making, including managing expenditures. Period-to-period comparisons of Adjusted EBITDA help our management identify additional trends in our financial results that may not be shown solely by period-to-period comparisons of net income (loss) or income (loss) from operations. Our management recognizes that Adjusted EBITDA has inherent limitations because of the excluded items, and may not be directly comparable to similarly titled metrics used by other companies. </font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We calculate Adjusted EBITDA as net income (loss) adjusted to exclude interest (income) expense, income tax expense (benefit), depreciation, impairment of goodwill and intangible assets, and amortization of intangible assets, which represent intangible assets resulting from pushdown accounting, legal and professional services fees related to Illumina&#8217;s acquisition of the Company in August 2021 (&#8220;the Acquisition&#8221;) and corresponding antitrust litigation, including compliance with the hold separate arrangements imposed by the European Commission, and our divestment from Illumina, restructuring charges, and stock-based compensation. We believe that the items subject to these further adjustments are not indicative of our ongoing operations due to their nature, especially considering the impact of certain items as a result of the Acquisition.<br><br>Adjusted EBITDA should be viewed as a measure of operating performance that is a supplement to, and not a substitute for, operating income or loss from operations, net earnings or loss and other U.S. GAAP measures of income (loss). Additionally, it is not intended to be a measure of free cash flow for management&#8217;s discretionary use, as it does not consider certain cash requirements such as interest and tax payments. Further, our definition of Adjusted EBITDA may differ from similarly titled measures used by other companies and therefore may not be comparable among companies. The following table presents a reconciliation of net loss, the most directly comparable financial measure calculated in accordance with U.S. GAAP, to Adjusted EBITDA on a consolidated basis.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Full reconciliation of these non-GAAP measures to the most comparable GAAP measures is set forth in tabular form below.</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</font></div></div></div><div id="i31f92041a1ef47c1a35aab23b6b6fb59_16"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Forward-Looking Statements</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This press release contains forward-looking statements. In some cases, you can identify these statements by forward-looking words such as &#8220;aim,&#8221; &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;continue,&#8221; &#8220;could,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;intend,&#8221; &#8220;may,&#8221; &#8220;might,&#8221; &#8220;plan,&#8221; &#8220;potential,&#8221; &#8220;predict,&#8221; &#8220;should,&#8221; &#8220;would,&#8221; or &#8220;will,&#8221; the negative of these terms, and other comparable terminology. These forward-looking statements, which are subject to risks, uncertainties, and assumptions about us, may include expectations and projections of our future financial performance, future tests or products, patient awareness of our products, technology, clinical studies, safety results, regulatory compliance, potential market opportunity, anticipated growth strategies, restructuring costs, sufficiency of cash on hand to finance our business, cost savings, budgets and strategies, impact of the restructuring on our operations and growth and anticipated trends in our business.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These statements are only predictions based on our current expectations and projections about future events and trends. There are important factors that could cause our actual results, level of activity, performance, or achievements to differ materially and adversely from those expressed or implied by the forward-looking statements, including those factors and numerous associated risks discussed under the sections entitled &#8220;Risk Factors&#8221; in our Annual Report on Form 10-K for the period ended December 31, 2024 and in our Quarterly Report on Form 10-Q for the period ended June&#160;30, 2025 (the &#8220;Form 10-Q&#8221;). Moreover, we operate in a dynamic and rapidly changing environment. New risks emerge from time to time. It is not possible for our management to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results, level of activity, performance, or achievements to differ materially and adversely from those contained in any forward-looking statements we may make.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forward-looking statements relate to the future and, accordingly, are subject to inherent uncertainties, risks, and changes in circumstances that are difficult to predict and many of which are outside of our control. Although we believe the expectations and projections expressed or implied by the forward-looking statements are reasonable, we cannot guarantee future results, level of activity, performance, or achievements. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Except to the extent required by law, we undertake no obligation to update any of these forward-looking statements after the date of this press release to conform our prior statements to actual results or revised expectations or to reflect new information or the occurrence of unanticipated events.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GRAIL Contacts</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate Communications&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Kristen Davis&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trish Rowland&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">pr&#64;grail.com</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investor Relations</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Alex Dobbin</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Alexis Tosti</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ir&#64;grail.com</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</font></div></div></div><div id="i31f92041a1ef47c1a35aab23b6b6fb59_19"></div><hr style="page-break-after:always"><div style="min-height:90pt;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">GRAIL, Inc.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Condensed Consolidated Balance Sheets</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(unaudited)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(amounts in thousands, except for share and per share data)</font></div><div style="text-align:center"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.682%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.688%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.689%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">June 30,<br>2025</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;text-indent:4.5pt;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">December 31,<br>2024</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Assets</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Current assets&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</font></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">127,427&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">214,234&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Short-term marketable securities</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">475,327&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">549,236&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivables, net</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">16,313&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">20,312&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Supplies</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">19,739&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">18,632&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">13,038&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">17,447&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current assets</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">651,844&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">819,861&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property and equipment, net</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">60,210&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">69,061&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">60,033&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">66,373&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted cash</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">3,349&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">3,349&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets, net</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">1,919,723&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">2,016,890&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current assets</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">7,392&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">7,773&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total assets</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">2,702,551&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">2,983,307&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Liabilities and stockholders&#8217;&#47;member's equity</font></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Current liabilities&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</font></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">6,283&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">4,844&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued liabilities</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">48,870&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">57,241&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease liabilities, current portion</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">13,689&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">13,260&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current liabilities</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">1,797&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">1,580&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current liabilities</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">70,639&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">76,925&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease liabilities, net of current portion</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">48,475&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">54,881&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax liability, net</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">266,174&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">345,860&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current liabilities</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">2,620&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">2,236&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total liabilities</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">387,908&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">479,902&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Preferred stock, par value of $0.001 per share&#59; 50,000,000 shares authorized, no shares issued and outstanding as of June 30, 2025 and December 31, 2024</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock $0.001 par value per share, 1,500,000,000 shares authorized, 36,047,799 shares issued and outstanding as of June 30, 2025, 33,893,409 shares issued and outstanding as of December 31, 2024</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additional paid-in capital</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,335,832&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,305,250&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated other comprehensive income</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,303&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,451&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated deficit</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10,023,528)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,803,330)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total stockholders'&#47;member&#8217;s equity</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,314,643&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,503,405&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total liabilities and stockholders'&#47;member&#8217;s equity</font></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,702,551&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,983,307&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</font></div></div></div><div id="i31f92041a1ef47c1a35aab23b6b6fb59_22"></div><hr style="page-break-after:always"><div style="min-height:108pt;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">GRAIL, Inc.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Operations</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(unaudited)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(amounts in thousands, except share and per share data)</font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br>2025</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br>2024</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br>2025</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br>2024</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Revenue&#58;</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Screening revenue</font></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,379&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,163&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63,512&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51,702&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Development services revenue</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,165&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,807&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,869&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,989&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenue</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35,544&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,970&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67,381&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58,691&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Costs and operating expenses&#58;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of screening revenue (exclusive of amortization of intangible assets)</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,346&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,789&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,469&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,511&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of development services revenue</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">501&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">621&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,672&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,057&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of revenue &#8212; amortization of intangible assets</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,472&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,472&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66,944&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66,944&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46,626&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">94,196&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100,251&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">195,821&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sales and marketing</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,539&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,989&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63,518&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">87,808&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37,914&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67,258&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82,988&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">124,327&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill and intangible assets impairment</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,000&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,420,936&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,000&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,420,936&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total costs and operating expenses</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">194,398&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,673,261&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">379,842&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,927,404&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss from operations</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(158,854)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,641,291)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(312,461)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,868,713)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other income (expense)&#58;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest income</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,809&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,805&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,588&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,706&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income (expense), net</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(811)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,395)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total other income, net</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,998&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,810&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,193&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,753&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss before income taxes</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(152,856)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,638,481)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(299,268)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,862,960)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefit from income taxes</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38,871&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53,144&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">79,070&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58,709&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net loss</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(113,985)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,585,337)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(220,198)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,804,251)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;text-indent:-7.21pt;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss per share &#8212; Basic and Diluted</font></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3.18)</font></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(51.06)</font></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6.28)</font></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(58.11)</font></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17.08pt;text-align:left;text-indent:-8.64pt;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average shares of common stock used in computing net loss per share&#58;</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35,793,154&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,049,148</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35,054,896&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,049,148</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</font></div></div></div><div id="i31f92041a1ef47c1a35aab23b6b6fb59_25"></div><hr style="page-break-after:always"><div style="min-height:108pt;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">GRAIL, Inc.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Reconciliation of GAAP to Non-GAAP Financial Measures</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(unaudited)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(amounts in thousands)</font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br>2025</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br>2024</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br>2025</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br>2024</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross loss </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</font></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17,775)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17,912)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37,704)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39,821)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.45pt;text-align:left;vertical-align:top"><font style="color:#231f20;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:83%">Amortization of intangible assets</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,472&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,472&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,944&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,944&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">417&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">463&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,179&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">944&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjusted Gross Profit</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,114&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,023&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,419&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,067&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">___________</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.65pt">Gross loss is calculated as total revenue less cost of screening revenue (exclusive of amortization of intangible assets), cost of development services revenue and cost of revenue&#8212;amortization of intangible assets.</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:108pt;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">GRAIL, Inc.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Reconciliation of GAAP to Non-GAAP Financial Measures</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(unaudited)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(amounts in thousands)</font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br>2025</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br>2024</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br>2025</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br>2024</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#231f20;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:107%">Net loss</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(113,985)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,585,337)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(220,198)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,804,251)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#231f20;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:83%">Adjusted to exclude the following&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17.9pt;text-align:left;vertical-align:top"><font style="color:#231f20;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Interest income</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,809)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,805)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14,588)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,706)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17.9pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefit from income tax expense</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(38,871)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(53,144)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(79,070)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(58,709)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:16.9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of intangible assets </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,583&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,583&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69,167&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69,167&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17.9pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,592&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,805&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,287&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,218&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:16.9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill and intangible impairment </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </font></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,000&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,420,936&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,000&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,420,936&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:16.9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Illumina&#47;GRAIL merger &#38; divestiture legal and professional services costs </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,624&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,932&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:16.9pt"><font style="color:#231f20;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Stock-based compensation </font><font style="color:#231f20;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</font></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,168&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,947&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,379&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,053&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:16.9pt"><font style="color:#231f20;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Restructuring</font><font style="color:#231f20;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline">(5)</font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(34)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjusted EBITDA</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(78,322)</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(139,391)</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(177,057)</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(291,360)</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">___________</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.65pt">Represents amortization of intangible assets, including developed technology and trade names.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.65pt">Reflects impairment of the goodwill and intangible assets recognized as a result of the Acquisition.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.65pt">Represents legal and professional services costs associated with the Acquisition and corresponding antitrust litigation, including compliance with the hold separate arrangements imposed by the European Commission, and legal and professional services costs associated with the divestiture.</font></div><div style="margin-top:0.1pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(4)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.65pt">Represents all stock-based compensation recognized on our</font><font style="color:#231f20;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> standalone financial statements for the periods presented.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(5)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.65pt">Represents employee severance, benefits, payroll taxes, and other costs associated with the Restructuring Plan.</font></div><div><font><br></font></div><div style="margin-top:0.05pt;text-indent:-2pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>gral-20250812.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:57da9d89-77bb-4c54-806c-dfb4b2da70cb,g:3977d86e-9362-479c-ad17-043a818fc942-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:gral="http://www.grailbio.com/20250812" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.grailbio.com/20250812">
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="gral-20250812_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="gral-20250812_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.grailbio.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>gral-20250812_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:57da9d89-77bb-4c54-806c-dfb4b2da70cb,g:3977d86e-9362-479c-ad17-043a818fc942-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_SolicitingMaterial_7e73e02c-ddbd-42ec-b3c2-fe086b65d43d_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_925b34c7-bc27-41dd-bfb7-2e6ebc0bee73_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_27ee2b3e-0592-4cd5-93dd-08089c3b522b_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_6e74fffd-dca7-4d31-9a53-12d27c0ecd23_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityExTransitionPeriod_de6178fa-346b-4233-8f25-3e945e25a5d7_terseLabel_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:label id="lab_dei_EntityExTransitionPeriod_label_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityExTransitionPeriod" xlink:to="lab_dei_EntityExTransitionPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_19354c8c-de5e-41e5-95be-fd86f95ca684_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_5d6d46b4-f039-4a45-b8c8-776801915218_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_3b5bc511-cc3a-476b-a8d4-edd021c34534_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_463c0670-633f-44dc-adc2-bf4ae8a0a32a_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_afea895c-160d-44ed-a5c4-c230227615c3_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_e38ff6b1-6184-4152-b332-962b958e3750_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_3aab72cf-69d2-43f4-8999-e3311978eb92_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_ff292fac-5558-48e7-811d-af57daeb0447_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_96b604b3-68f2-437b-8a82-02907b0308d4_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_b4a47901-20cd-42bd-99c0-8601a9f931be_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_214a01f1-dc38-4761-8094-52b31e062b92_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_0e02578f-c8a6-4a86-804d-293f7aff6176_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_3cc55ffe-72b8-484d-b249-57f00a3066e0_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_9d4e997b-5527-4b27-8799-a671037bdad8_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_eecd54d8-d532-4585-a6f9-ebca694b89f4_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_a5fc2615-406b-4a2e-8bbc-43bcc621dcf9_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_c06d7873-6fc8-4b47-ad46-911358b381d4_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_6ba4e68d-213b-489c-ae12-9b9338406c84_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>gral-20250812_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:57da9d89-77bb-4c54-806c-dfb4b2da70cb,g:3977d86e-9362-479c-ad17-043a818fc942-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.grailbio.com/role/Cover" xlink:type="simple" xlink:href="gral-20250812.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.grailbio.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_52ec5c8f-af91-4bd9-9f91-88e190bf7c4a" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_f09cc553-b66c-4546-859f-c1028910363c" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_52ec5c8f-af91-4bd9-9f91-88e190bf7c4a" xlink:to="loc_dei_AmendmentFlag_f09cc553-b66c-4546-859f-c1028910363c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_4fb096b4-2a71-4449-b1b6-1ae835d3a315" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_52ec5c8f-af91-4bd9-9f91-88e190bf7c4a" xlink:to="loc_dei_EntityCentralIndexKey_4fb096b4-2a71-4449-b1b6-1ae835d3a315" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_95dffb1a-f90a-413c-8af5-f0c684ad3680" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_52ec5c8f-af91-4bd9-9f91-88e190bf7c4a" xlink:to="loc_dei_DocumentType_95dffb1a-f90a-413c-8af5-f0c684ad3680" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_0e354aaf-03b2-4f5a-a488-61868b181c88" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_52ec5c8f-af91-4bd9-9f91-88e190bf7c4a" xlink:to="loc_dei_DocumentPeriodEndDate_0e354aaf-03b2-4f5a-a488-61868b181c88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_0cd7f2c6-9d7c-4ffb-b176-9f2d32d9fbfa" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_52ec5c8f-af91-4bd9-9f91-88e190bf7c4a" xlink:to="loc_dei_EntityRegistrantName_0cd7f2c6-9d7c-4ffb-b176-9f2d32d9fbfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_535b4a76-4f12-4d40-af04-f1ced8bfb991" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_52ec5c8f-af91-4bd9-9f91-88e190bf7c4a" xlink:to="loc_dei_EntityIncorporationStateCountryCode_535b4a76-4f12-4d40-af04-f1ced8bfb991" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_61afa29c-1d4a-438f-b7bc-5b4d143b8c70" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_52ec5c8f-af91-4bd9-9f91-88e190bf7c4a" xlink:to="loc_dei_EntityFileNumber_61afa29c-1d4a-438f-b7bc-5b4d143b8c70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_057a6d64-4829-4d59-985b-6ad8358b6d8c" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_52ec5c8f-af91-4bd9-9f91-88e190bf7c4a" xlink:to="loc_dei_EntityTaxIdentificationNumber_057a6d64-4829-4d59-985b-6ad8358b6d8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_f90c7c3d-0846-479c-a062-d81e16d0a2dd" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_52ec5c8f-af91-4bd9-9f91-88e190bf7c4a" xlink:to="loc_dei_EntityAddressAddressLine1_f90c7c3d-0846-479c-a062-d81e16d0a2dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_ce736df6-2b0f-4689-9e88-355c2e5f384a" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_52ec5c8f-af91-4bd9-9f91-88e190bf7c4a" xlink:to="loc_dei_EntityAddressCityOrTown_ce736df6-2b0f-4689-9e88-355c2e5f384a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_19ee54a0-7547-4cd9-a861-d1a562e7f905" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_52ec5c8f-af91-4bd9-9f91-88e190bf7c4a" xlink:to="loc_dei_EntityAddressStateOrProvince_19ee54a0-7547-4cd9-a861-d1a562e7f905" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_5faa0df0-6602-40a3-aade-5ac93262d07a" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_52ec5c8f-af91-4bd9-9f91-88e190bf7c4a" xlink:to="loc_dei_EntityAddressPostalZipCode_5faa0df0-6602-40a3-aade-5ac93262d07a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_73eb3414-750d-441e-ac7b-2f751f7b25f5" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_52ec5c8f-af91-4bd9-9f91-88e190bf7c4a" xlink:to="loc_dei_CityAreaCode_73eb3414-750d-441e-ac7b-2f751f7b25f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_78cdaa9e-b991-4be9-8240-c2c5c7ca938c" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_52ec5c8f-af91-4bd9-9f91-88e190bf7c4a" xlink:to="loc_dei_LocalPhoneNumber_78cdaa9e-b991-4be9-8240-c2c5c7ca938c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_06e83ee3-49e9-40de-a416-4cafd4fc7f67" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_52ec5c8f-af91-4bd9-9f91-88e190bf7c4a" xlink:to="loc_dei_WrittenCommunications_06e83ee3-49e9-40de-a416-4cafd4fc7f67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_f95f13f0-812b-453a-a92f-41be312541b3" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_52ec5c8f-af91-4bd9-9f91-88e190bf7c4a" xlink:to="loc_dei_SolicitingMaterial_f95f13f0-812b-453a-a92f-41be312541b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_714f44c3-94fd-4bf2-8365-d838055f5829" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_52ec5c8f-af91-4bd9-9f91-88e190bf7c4a" xlink:to="loc_dei_PreCommencementTenderOffer_714f44c3-94fd-4bf2-8365-d838055f5829" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_2de8305e-2636-42cc-afb8-cabf37b466be" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_52ec5c8f-af91-4bd9-9f91-88e190bf7c4a" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_2de8305e-2636-42cc-afb8-cabf37b466be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_6b40ab95-ac89-4c94-927c-4331df3b4a3a" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_52ec5c8f-af91-4bd9-9f91-88e190bf7c4a" xlink:to="loc_dei_Security12bTitle_6b40ab95-ac89-4c94-927c-4331df3b4a3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_c6f6f614-197e-4bf4-aaac-430640e0f630" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_52ec5c8f-af91-4bd9-9f91-88e190bf7c4a" xlink:to="loc_dei_TradingSymbol_c6f6f614-197e-4bf4-aaac-430640e0f630" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_37608132-aeb2-478b-b115-880a189356a7" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_52ec5c8f-af91-4bd9-9f91-88e190bf7c4a" xlink:to="loc_dei_SecurityExchangeName_37608132-aeb2-478b-b115-880a189356a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_555a690e-4e82-4a31-85c9-2c7fea202768" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_52ec5c8f-af91-4bd9-9f91-88e190bf7c4a" xlink:to="loc_dei_EntityEmergingGrowthCompany_555a690e-4e82-4a31-85c9-2c7fea202768" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod_5fefe4d9-fd32-4db2-b694-1d3a8a2ff420" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_52ec5c8f-af91-4bd9-9f91-88e190bf7c4a" xlink:to="loc_dei_EntityExTransitionPeriod_5fefe4d9-fd32-4db2-b694-1d3a8a2ff420" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>grail_logoxvelvet.jpg
<TEXT>
begin 644 grail_logoxvelvet.jpg
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MVU.Z\E04J         " @2A,L37=$GLOY:A)3)#BVUX7J&[KMODB$@
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MVF/=&^2/27Z*LA3LLJ/N^]3D!P!@W4Z2_)+DL2K*F4F7 *R))>2&=]X5T0
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M23Y*8J,4U    &"-%*:VK"M"W&=1C #X(].F (!-LT0P '\T$\'&?>R*:@
M , :*$QMR1^F2IU(!'B#:5, P";]5MH6!<!AZU[>N9#$5I@R!0   &NB,+4%
M55&>Q50I8'FF30$ F_9C593WW34, (=IFN1(#-O)WO4_    K(?"U(9513E+
M\N^8*@6\WX])[CRX!  VY$-W[F'*!<!ALO_?GJ,L"FL   # P!2F-J0JRM.J
M*.^3_"0-8  ?DOS;@TL 8$..DORS*LI;DRX #D=5E--XZ6_;7/<#  # &BA,
M;4!W<^D^BX(#P)#^617EG0>7 ,"&?$QBB3Z PS$5P=:=5$5Y(08    8EL+4
M&E5%>5P5Y3S)+UF\D0VP#N=)'MU !0 VY"2+29=340",5U>./9?$3C!E"@
M  :F,+4FW4VENR27T@ VX"C)_U1%>2T* &!#?NE>$ %@G)1T=L>YZ8X    P
M+(6I->C>M+Z+)?B S?NQ*LK[JBA/10$ ;,!E=^YA>6" $>FN*;T$N%L4V
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M , &_-2]9 + _E#&V7T?NF(;    L *%J25U2UK=Q=MVP/ZZ3')7%>6I* "
M=9]W*$T![(?N&O&C)/;"5 0   "P&H6I)2A+ 2/R(<E]MU\# %@GI2F _6"Z
MU'X=6T_%     .^G,-535933)/].<B0-8"2.8M(4 + 92E, .ZQ;MGTJB;VB
MX 8    K4)CJH2K*JR2_2 (8H:,D<S$  !MP617E3 P .VD:+PGNW3;KBFX
M  # .RA,O:%["_J?D@!&[+PJRHD8 ( -^*F;W@O ;C&M:/\<);D0 P   +R/
MPM0W=&6I2TD !V J @!@0WY1F@+8'5517B0YD<1>FHD     WD=AZBNJHCRN
MBO(NRE+ X3@3 0"P0;^8< FP,TR7VE\G7>$-    6)+"U!]417F<Y"[)N32
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MDN-O_-['W:]Y[5SD]#2IV^91# # COM0%>6L;IN9* !6U[U,.)7$0;B*<AP
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M5].GKKHE,J?=AS+CYOQ<MXV+2 !@;$ZJHKRJV^9:% "]7(G@X%U417EL^C3
MNUS'?>U=\-FS'P!@'493F*J*<I;DHTUZ,)[S>TGJ3AR[J[N0N<JB//4R=<K;
MK>MU4[?-3 S "/UL_S:*\_;C)&=?^4^G^<_)09/NQ^-X*8+_-*N*<N[!+T O
M4Q$<O*,L[LLXCP984MTVCU517B7Y11I;\^Q\!@!8EU$4IJJBG";YR>8\" ]9
MO-5QZP')7EY@WB:Y[2XRIUG<L+-DW\#?(W7;N( $8)?/![YD,8GR/>?]D^ZG
M9UD4J299E*R<3QP6#WX!^ATWIXZ1=*:.FP#OOH:=5T69*$UMPW.22=TVCZ(
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MI'2:Y.=X@/F09.*K @#6<LYQUY623[,H;)LZM=NNNH(  (ME9MTWPW$3
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M-C5)\O,.?:]=*"4"P'C//;*8-/59&FMG63Y@U+J7#B\E\4U/451>ADG7
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M5$4Y27(BB6]Z3G*[ZF]2M\UMDB=Q]C83 0   &/Q_;I^8].EMN)3W38R!P"
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MI"K*LW@!L8_KD?P98V+*%    'MKL,)4592G22Y%NG8/==NX&0$  (?M3@0
MH^$^S]L^=TO2KE4WP>I&W+V==X4_    V#M#3IB:BG,CY P   >N;IO')$^2
M>!</=H&=X07$WN8C_;/&0.$/  " O31D8<K%\?K]O(FWZ0  @+W@VN!]CD4
M[)"I"-[T5+?-?%-_6-TV=TD>Q-[;9564CJT   #LG4$*4U513I,<B7.M'NJV
MF8D!  #H*$P![#\O(+YMOH4_\UKLOHX!   8MZ$F3+DH7K^I"   @%?N1/ N
MIF  .\$+B+UMO+S43;1Z%GUO[@T#  "P=U8N3%5%>9;D@RC7RE)\  # 'SV*
MX%W.1 #LB)D(WG13M\V7+?W9IDSU=]05  $  &!O##%ARAM$ZV4I/@  X$_J
MMGF4 L!^JHIRDN1$$F_:9FEI+OZEN$<,  # 7EFI,%45Y7&2"S&NE9L-  #
M7WD0 <!><K_G;9^W.7&]*R;?V R]?>B*@    + 75ITP=9'D2(QK<U.WS9T8
M  " O_!%! #[I2K*TR0?)?&FN<]A[R@" @  L#=6+4Q-1;@VSW&3 0  ^+8[
M$0#LG9D(WO1<M\U\VY]$]R*C:8[]?>P*@0   +#SWEV8ZBY^ST6X-K.Z;;PM
M#@  ,"S7L<#65$5YG,7$=K[MVN>RM[P "@  P%Y89<+45'QK\U"WC9LQ  #
M6QY% +!7IDF.Q/"F^0Y]+K=93(*GY]=X5PP$  " G:8PM9N\B04  /3Q* *
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M-3S3I0    !&J"K*:;Q\V,<^W1N;V5Q+F8H   " 7:0PM7VF2P$  &S.9Q$
M&V2ZSMN>ZK:YVY=/MIN$Y5C2WTE7' 0  ("=TKLP93F^M3!="@   &"$JJ*<
M)/D@B3?-]O!S=C]O.8J#    [)QE)DQ-Q#6XN>E2     *.D)/*VYR2W^_9)
MUVUSF^3)YNOM0U<@!   @)VQ3&'*<GS#\S8:  #P;AX^ NSL_ODTR4=)O&F?
M7R9T7V\Y4Q$   "P2WH5IJJB/$MR(JY!W=1M\R@&    @-$Q7:J??2X=S;.8
MD$4_EUV1$    '9"WPE3$U$-SEMH    FW<O F"=JJ(\CFDZ?7S:YY<)N\E8
MMS;C4A0) 0  V!E]"U-340WJ<]TV;M(#  "K.A/!TKZ( %BS:9(C,;QI/H*_
MP\QF7.Y[HRL4 @  P-:]69CJ+F(_B&I0IDL!  !#\- 18/>8HO.VI[IM]GXZ
M4S<AZ[/-V=M1D@LQ    L OZ3)B:B&E0H[@A!   [ 2%J>69, 6L3564%TE.
M)/&F,;U,.+<YES(3 0   +N@3V'*6S_#FHL    8B"7YEF=Y=&"=3)=ZVW-&
M='^L;IMYDB>;M;>3KE@(    6V7"U.;-10    SD5 0 NZ$JRK,DYY)XTVW=
M-F.;]C>W69>B6 @  ,#6?;,P517E:8P1']*GNFT>Q0    S$]=KR7),!ZZ($
MTL]LA'^G:YMU*>?=?6<   #8FK<F3!F//*RY"   @"%413F1PO*\Q *L:9]\
MG.12$F_Z/,;]<#<QZ\;F7<I,!    &S36X6IB8@&\U2WS:T8  " @9R)8&G/
M(@#6Q'2I?J[]W>A<=D5#    V J%J<U1E@(  (:D,+6\>Q$ :Z(P];91OTQ8
MM\U]DL\VL^\;    ]L-?%J:JHCQ+<B2BP7C+#   &)+"U/*^B  86E64T[B'
MUL<AW!N;V\Q+F8H   " ;?G6A*F)> ;S4+?-HQ@  ( A=$O8?)#$TDR8 M;!
ME)Q^YF/_"]9M,X_E7Y=QTA4. 0  8.,4IC9C+@(  &! KM?>YU$$P)"JHIQ$
M@;6/F[IM#F7*GRGSRU$X!   8"N^59BRO,-P;D4    ,:"*"=WD4 3 P98]^
M#JE$-+>YE_*A*QX"  # 1GVU,%45Y6F2$_$,PG)\  # T"Y$\"Z6Y ,&T]T_
M^RB)-WVNV^9@]K_=?< ;FWTI4Q$   "P:7\U86HBFL',10    S%"R[O]GQ
MRT$!FV&Z5#]S?V?><-F=WP   ,#&_%5ARG)\P[$<'P  ,"33I=['="E@,%51
M'L=4G#Z>ZK:9']I?NFZ;NR0/-O]2?#\!  "P40I3ZV4Y/@  8&A3$;R+PA0P
MI(LD1V)XT_R _^[7-O]2KKHB(@   &S$7Q6FSD4S"-.E  " P73+U7R0Q+L\
MB@ 8T$P$O1QL::B;K/7L2Z"WHYBB"0  P ;]J3!5%>5$+(-1F (  (9T)8)W
M,V$*&$15E!=)3B3QIINZ;;X<> :F3"UG)@(    VY6L3IBS'-XRGNFW<D <
M (9D\L([U6US)P5@(,JK_<Q%((,EG7B9%P  @$U1F%J?.Q$   !#,=%D)0\B
M  ;:%Y\F.9?$V_M=1=6D;IO'))]\.2QE)@(    VX6N%J5.Q#,)R?   P)!,
M-'D_TW^!H<Q$T(NEZ&3Q7N==,1$   #6ZFN%*6_)#>-.!   P!"JHCQSK>;Z
M#-CZOO@XR:4DWO1<M\U<# O=I*TG22QE)@(   #6[3\*4]U->%;W4+?-%S$
M   #,5UJ-29, ?;%FV.BTI_-1+"4BZZ@"    &OSQPE3"E/#N!,!   PA&Y9
M&A--WN^Y;AN%*6 (4Q'T,A?!G]PF>19#;T=14 0  &#-_EB8.A7)(.Y$
M#&0F M=GP'9513E-<B*)-]W4;?,HAO_43:*?2V(I4Q$   "P3G\L3$U$,H@[
M$0   *OJEDTW7<KU&;!]IMWT,Q?!7[)4X7).NJ(B    K(4)4\-[Z-X: P
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M84P^B@" 0]4MP7<72SMMTHV))\"*U^/*K6][JMMF+H;UJMOF/LF#)):B\ @
M ,"[6))O& I3K$IQD5&IBG(B!0 .\/@W2_+O)!^DL5&F<0"KF(F@E[D('-=V
MU%&W##(    LQ9)\ ^C>_H)5>)L5 &!/545Y5A7E?9*?I+%QGUV/ 2OLOR=)
M3B31BQ+/AG23O)XEL929"    %B6"5,   #O4!7E<564US%5:IMF(@#L0];N
MIFX;T]4W2T%M.2<F70,  +"L[V(IL%4]B0    Y+M_3+8Y(?I;$UG^NVN1,#
M\,[]^&F2<TGTHKRS>7,1+.U*!    "S#DGRK>Q0!   <AJHH+ZJB?$SR2RRK
MO&TS$0#V(6MGZ=,MJ-OF,<F-));RL2M" @  0"_?BP   .#;NF5>9C&-9%=\
M,ET*6&&??ISD0A*]S$6PU>POQ;"469*I&    .C#A"D  ("_4!7EM)LH]6N4
MI7:)97> 5?<AI@2^[:ENF[D8MJ,K!C](8BD772$2    WO1]DC,QK.1.!
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M  ![H9L:=9S?BU&G23Y(9O2F==M\$0.P(L7+?DR7VEVS)+^(8;ESB"XW
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M  " @V=)OM6=B@   .";E*6 =9N)H)>GNFUNQ3 N==O<)_DLB:4<=45+
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M"I@    <$$OR#>-,!   P(%Z3O(/#^.!3:J*\B+)B21ZL7\^/-<B6)H")@
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M)?F&<R8"  !@I/Y5M\U9-ZT"8)L4IOIYKMMF+H;#5K?-7:PL8#\#O)=K'P"
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MTS3)O\4  ,":/">Y,GT$V#.FN_1GR37>,D\RBQ+B,HZ27$0A$7BE;IM[*0
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M$2F"),#K.L=GLXYC2S?-X<S@F6<420$CH#CA^:8B8$E749"XK-.J*(]=?0D
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MYW696H^CJBA/Q    'N['IB* > O&2N!(3K,HN 3  "  ?JS@JEKT:S-F0@
M &!OO7.( N#/545YGN1($L! 344    P3#I,]6\B @  V&OSJBA?BP'@#UV*
M !BPHZHHS\0    P/#I,]>]-593'8@  @+UUE.1*# "_UNV7G$H"&+BI"
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M7'2;C0  ,$C=5=X?)=&;P^C\"^R.J0@ GNW(WB\  ,!V';SPOY^)L%=7(@
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MKL,7 $!O7O7T^UYU"SL/.S;CHBK*:U7V   ,5=TV=]UI^G]*HS<_=^N&6U$
M*W)5%$#_WE1%>5:WS;4H8*?6K ]1S @ ,"I]7,GW-'%T<GFS?JF*\D0,   ,
M57=Z]*,D>C6KBO*U&(!E545YG.2M)  V0H$J  ! SPYZ_+UGXMVXZVX#$P
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MT9F@3V^JHM0Q!?:3A_'+F8D 5C(5P<ISM#,Q    O-S!%O_L:3S@V!47BJ8
M !B2KIO'1!*]^M$#.=@O55$>)WDKB6>[K]M&EQQ8?2ZG8^AJ%+8"  "LP=8*
MIKI%L1/+N^.B*LK;JBA?BP( @"'H'E)_DD2OYM8(L%<\A%^.?2UXF9D(5O*V
M*W %  #@!;;982IUVTR3W'L9=L:;)-=549Z( GZO*LIS*0# SIE84_3J,!YF
MPKZL=UY'Y[YE/!H?X67JMIF9QZU,@2L  , +'>S US#Q,NR4IZ*I,U' %U51
M7B7YIR0 8+?4;?-@3=&[MU51>B@'XS?)HDB2YYEWGT' R\Q$L-J8K0LH  #
MRVR]8*INF^NX1F/7'";YEX<BD%1%>5(5Y6V2'Z4! +NI6U.\ET2OICK1PNC9
M UAR7!0!K(6K+5=SF$0G=   @!<XV)&O8Y)%*W-VR\]54<Z=5F)?=46#_\ZB
M\QH L,.ZZ[X_2Z(WKN:#<:]]SI,<2>+9;NJVN1,#K&4.]Y#DHR16,A4!  #
MZG:B8*I;&%O@[::W65S1YS0Y>Z,JRN.J**^3_"P- !B421S$Z-.;[IIB8'QT
MEUJ.L1"\IW;!45?P"@  P IVI<-4ZK:Y2G+C)=E);[(HFIJ(@K'KNDK=)CF5
M!@ ,2]TVMW$0HV\_5D5Y)@88U1KHQ/IG*?=UV\S% &N?P]D77HV"5P  @!4=
M[-C78X&WNPZ3_.**/L:J*LJ3JBAOL^@J=2@1 !@F!S$VPIH QL5>S')F(@#O
MK1UR6A7EL1@   "6MU,%4]UIHO=>EIWV-LFM4^6,1564KZNBG";Y=Q;=U "
MX3N/J_GZ=!@/-6$TZZ$D%Y)8BJO#H =UV\S,WU8V%0$  ,#R=JW#5.JVF2;Y
M[*79:4=)_E45Y963Y0Q9593G65R_]TX: # >==L\))E(HE=ONZN,@6'S/E[.
MQ^XS!NB'@L357-BC!0  6-[!CGY=$R_-(/P8W:88H*HHCZNBO$[RSRP*  &
MD:G;9I[D@R1Z-:V*\D0,,&@*II:CF /Z-1.!\1P  &!3=K)@RM5\@Z+;%(/1
M7;]WE>0_24XE @"C-TUR+X;>N)H/AKT^FG3O8Y[GIMNO GI2M\U=DH^26,E$
M!    ,O9U0Y3KN8;GJ=N4^>B8-=TA5+3)'?=WU4 8 ]TUR:9G_;K35>0#@R/
M;B3+F8D O-=VV%%7" L  , S'>SXUW>>Y-'+-)R%>9)_5D4YKXKR6!SL@FZS
MZ#;)NS@]#0![1_?:C?C1-=TPN'7269(WDGBV^[IM9F* C<S=KN,0[:H4P@(
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MBZ5N_F<]T=_<>][-28'UNQ3!<FL8ASY@&.JVN:N*\B9?[=_Q;!=544X5K ,
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M" , OU\_7"=Y+XE>O:F*<BH&^+6N^]J%))8R$P&,FBY3JYN(    V#<*IOY
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M1AK !KROV^:X&WL @-TTB0X'?7M7%>6)&!CAV,%R9B( OC*/@ZVK.C6W @
MQDK!5(^Z*_K.DOPD#: G-TF^J]MF*@H V/WU010^;,*\*LK78F ,JJ(\3G(A
MB:5\ZJY"!?AZ#C:3Q,HN10   (R1@JG-+,JODOP]R6=I &MRG^0?==N<>1@
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M5] +   P"@JF=D37;>HD3IC#OON8Y+NZ;:9.1P/ 7JP#'I),)-&[>564K\7
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MU+58         ("A4##%Z'6%5$]=J8Z['R=)#J7SAYZ*HF[SI3CJH6Z;6]$
M         $.G8(J]5A7E21;%5,?=CZ?"JF2<155/Q5!/!5')HB J26[KMGGP
MMP(         &#,%4_ ,79>J)U__\]<%5D^.T^]5@(_Y4NSTY*[[\>2I.U2R
DN#;OSJL(         )#\?\M3^Z8P12@8     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Aug. 12, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001699031<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Aug. 12,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">GRAIL, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-42045<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">86-3673636<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1525 O&#8217;Brien Drive<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Menlo Park<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">833<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">694-2553<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.001 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">GRAL<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="gral-20250812.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.grailbio.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="gral-20250812.htm">gral-20250812.htm</File>
    <File>gral-20250812.xsd</File>
    <File>gral-20250812_lab.xml</File>
    <File>gral-20250812_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="25">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "gral-20250812.htm": {
   "nsprefix": "gral",
   "nsuri": "http://www.grailbio.com/20250812",
   "dts": {
    "inline": {
     "local": [
      "gral-20250812.htm"
     ]
    },
    "schema": {
     "local": [
      "gral-20250812.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "gral-20250812_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "gral-20250812_pre.xml"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 24,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 25
   },
   "report": {
    "R1": {
     "role": "http://www.grailbio.com/role/Cover",
     "longName": "0000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gral-20250812.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gral-20250812.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.grailbio.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.grailbio.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.grailbio.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://www.grailbio.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.grailbio.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.grailbio.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.grailbio.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.grailbio.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.grailbio.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.grailbio.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://www.grailbio.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Ex Transition Period",
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.grailbio.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.grailbio.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.grailbio.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.grailbio.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.grailbio.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.grailbio.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Issuer Tender Offer",
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.grailbio.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Tender Offer",
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.grailbio.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.grailbio.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.grailbio.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Soliciting Material",
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.grailbio.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.grailbio.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Written Communications",
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001699031-25-000162-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001699031-25-000162-xbrl.zip
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MOV=,A=2MR0<FJ/?B7.]E1!^3VHQ0;9:R(G 8$!#*-R1^X Z49R$ %TGEQG6
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M2X6<+YS<#4"$M6*#"(>1SF83R?0L('1V/H@O5> ZPTVO;R,]]5[!&#?7K]1
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MERL8;]?^_]D&.L-^K9>3/U!+ P04    "  Q@ Q;- 1)YV *   "6   %0
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MX#T+;X['X;QU%F@_<H>P;4>=BV,K\/99<F*O,^AD^.VS52=P[UI[""\*9<Y
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MQ9C!L=/C(<;'W> _:XCLM-DS2G8_QW6@O&(/GZ2.G":;MYPV;Y*P1#&B3^I
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M2=OC72C4*ZJ[R/?35]M[TO57QIZ^^C]02P,$%     @ ,8 ,6Z\BV;;=!@
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M3!D3;D3NA=*]R>+-X@F/%W#@Y.#AA^ZE^R^)DX/_ %!+ 0(4 Q0    ( #&
M#%OT*.#?LS$  ')M @ >              "  0    !E>#DY,3(P,C5Q,F5A
M<FYI;F=S<')E<W-R92YH=&U02P$"% ,4    "  Q@ Q;,N#J.)</  #"<
M$0              @ 'O,0  9W)A;"TR,#(U,#@Q,BYH=&U02P$"% ,4
M"  Q@ Q;Z_?L96 "  #Y!@  $0              @ &U00  9W)A;"TR,#(U
M,#@Q,BYX<V102P$"% ,4    "  Q@ Q;- 1)YV *   "6   %0
M    @ %$1   9W)A;"TR,#(U,#@Q,E]L86(N>&UL4$L! A0#%     @ ,8 ,
M6Z\BV;;=!@  ]3(  !4              ( !UTX  &=R86PM,C R-3 X,3)?
=<')E+GAM;%!+!08     !0 % % !  #G50     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>gral-20250812_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="gral-20250812.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001699031</identifier>
        </entity>
        <period>
            <startDate>2025-08-12</startDate>
            <endDate>2025-08-12</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-24">0001699031</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="c-1" id="f-25">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="c-1" id="f-1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-2">2025-08-12</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="c-1" id="f-3">GRAIL, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-4">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">001-42045</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-6">86-3673636</dei:EntityTaxIdentificationNumber>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-7">86-3673636</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-8">1525 O&#x2019;Brien Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-9">Menlo Park</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-10">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-11">94025</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-12">94025</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-13">833</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-14">694-2553</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="c-1" id="f-15">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="c-1" id="f-16">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="c-1" id="f-17">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="c-1" id="f-18">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="c-1" id="f-19">Common Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-20">GRAL</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-21">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-22">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="c-1" id="f-23">true</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
